Rwanda vs Sub-Saharan Africa: Access to anti-retroviral drugs, female
Rwanda
97.0%
in 2024
Sub-Saharan Africa
86.3%
in 2024
Rwanda rank
12th
Sub-Saharan Africa rank
10th
Access to anti-retroviral drugs, female over time
- Rwanda
- Sub-Saharan Africa
How they compare
Rwanda currently reports 97.0% against 86.3% in Sub-Saharan Africa, a difference of 10.7%.
That makes Rwanda's figure about 1.1 times Sub-Saharan Africa's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Sub-Saharan Africa ahead.
Rwanda ranks 12th and Sub-Saharan Africa ranks 10th of 141 countries.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Rwanda | Sub-Saharan Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.1% | 5.8% | 5.3% | Rwanda |
| 2010s | 63.3% | 50.9% | 12.4% | Rwanda |
| 2020s | 90.8% | 81.3% | 9.5% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Rwanda or Sub-Saharan Africa?
- Rwanda, at 97.0% against 86.3% in Sub-Saharan Africa as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Rwanda and Sub-Saharan Africa?
- 10.7%, with Rwanda ahead.
- How many years of comparable data are there for Rwanda and Sub-Saharan Africa?
- 25 years are reported by both, from 2000 to 2024.
- How do Rwanda and Sub-Saharan Africa rank globally for access to anti-retroviral drugs, female?
- Rwanda ranks 12th and Sub-Saharan Africa ranks 10th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.